In the IMvigor011 trial, ctDNA-guided adjuvant atezolizumab reduced the risk of disease recurrence or death by 36% and the ...

FDA approves atezolizumab and a companion diagnostic for adjuvant treatment of MIBC in patients with detected circulating tumor DNA after surgery. The US Food and Drug Administration (FDA) has ...

With the help of DNA testing company Natera and its personalized molecular residual disease (MRD) blood test Signatera, Roche ...

The FDA has approved atezolizumab and atezolizumab with hyaluronidase-tqjs as adjuvant treatment for certain adults with ...

Natera said the Food and Drug Administration approved its Signatera CDx as a test for bladder cancer. The drug can be used as a companion diagnostic with adjuvant atezolizumab to treat muscle-invasive ...

The assay delivers a risk score that can help clinicians to tailor treatment intensity to a patient's risk of disease progression.

Vesta Bladder Risk Stratify Dx applies Valar Labs' proprietary AI foundation models to standard hematoxylin and eosin (H&E) stained pathology slides-the slides produced as part of routine clinical ...

AIMEE Knight was diagnosed with incurable ovarian cancer – despite having her ovaries removed after watching her mum “slowly ...

A mom has been diagnosed with incurable ovarian cancer – despite having her ovaries removed when she lost her mom and ...

Aimee Knight, 50, has been diagnosed with stage 3 ovarian cancer despite having her ovaries removed in 2015 as a preventative ...

Jimi Stewart, a rollerblading enthusiast from Austin, Texas, was diagnosed with a type of non-muscle invasive bladder cancer ...